How to resolve a clinical and molecular puzzle: concomitant monoclonal gammopathy of undetermined significance (MGUS) with neutrophilia and clonal hematopoiesis of indeterminate potential (CHIP)

被引：0
|
作者：
Simon Haefliger
Darius Juskevicius
Sylvia Höller
Ulrich Buser
Stefan Dirnhofer
Alexandar Tzankov
机构：
[1] University of Basel,Institute of Pathology
[2] University Hospital Basel,undefined
来源：
Annals of Hematology | 2019年 / 98卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2431 / 2432
页数：1
相关论文
共 50 条
  • [41] Clinical significance of the monoclonal gammopathy of undetermined significance (MGUS)-like phenotype in patients with AL amyloidosis treated with Bortezomib-Containing Regimens (BCR) at the Amyloidosis Program of Calgary (APC)
    Zepeda, Victor Jimenez
    Prefontaine, Amiee
    Mahe, Etienne
    McCulloch, Sylvia
    Tay, Jason
    Duggan, Peter
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S127 - S128
  • [42] Clinical relevance of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) serum levels in monoclonal gammopathy of undetermined significance (MGUS)
    Bladé, J
    Filella, X
    Montoto, S
    Bosch, F
    Molina, R
    Coca, F
    López-Guillermo, AL
    Cid, J
    Ballesta, AM
    Montserrat, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 9 - 9
  • [43] First description of primary cerebral lymphoma associated with clonal hematopoiesis of undetermined potential (CHIP) and synchronous myelodysplastic syndrome - pathogenetic and clinical implications
    Treiber, H.
    Ganster, C.
    Schanz, J.
    Shimono, J.
    Zechel, S.
    Pohanyar, N.
    Riedel, C.
    Stadelmann, C.
    Haase, D.
    Truemper, L.
    Chapuy, B.
    Wulf, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 137 - 137
  • [44] Identifying risk factors of monoclonal gammopathy of undetermined significance (MGUS): a population-based study using data from the UK clinical practice research datalink (CPRD)
    Koshiaris, Constantinos
    Wang, Ariel
    Ramasamy, Karthik
    McShane, Charlene
    Nicholson, Brian D.
    Drayson, Mark
    Willis, Fenella
    Renwick, Suzanne
    Laketic-Ljubojevic, Ira
    Javaid, M. Kassim
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S131 - S131
  • [45] Clinical relevance of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) serum levels in monoclonal gammopathy of undetermined significance (MGUS).
    Blade, J
    Filella, X
    Montoto, S
    Bosch, F
    Molina, R
    Coca, F
    LopezGuillermo, A
    Cid, J
    Ballesta, AM
    Montserrat, E
    BLOOD, 1997, 90 (10) : 1564 - 1564
  • [46] Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)
    Boddicker, Nicholas J.
    O'Brien, Daniel R.
    Braggio, Esteban
    Achenbach, Sara J.
    Chaffee, Kari G.
    Norman, Aaron D.
    Vachon, Celine M.
    Kabat, Brian
    Call, Timothy G.
    Parikh, Sameer A.
    Leis, Jose F.
    Ding, Wei
    Muchtar, Eli
    Cerhan, James R.
    Shanafelt, Tait D.
    Kay, Neil E.
    Caporaso, Neil E.
    Slager, Susan L.
    BLOOD, 2018, 132
  • [47] HIGH PREVALENCE OF IDIOPATHIC DYPSLASIA OF UNDETERMINED SIGNIFICANCE (IDUS) AND CLONAL HEMATOPOIESIS OF INDETEMINATE POTENTIAL (CHIP) AMONG RELATIVES OF HEMATOLOGIC NEOPLASMS WITH GERMLINE PREDISPOSITION PATIENTS
    Novoa, S.
    Torres-Esquius, S.
    Tazon-Vega, B.
    Blanco, A.
    Saumell, S.
    Perez Gonzalez, A.
    Molero Yordi, A.
    Garrido, S.
    Bosch, M.
    Valcarcel, D.
    Jerez, A.
    Montoro, M. J.
    LEUKEMIA RESEARCH, 2023, 128
  • [48] Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.
    Krishnan, Tharani
    Vasconcelos, Joao Paulo Solar
    Titmuss, Emma
    Topham, James Thomas
    Schaeffer, David F.
    Karsan, Aly
    Lim, Howard J.
    Ho, Cheryl
    Gill, Sharlene
    Kennecke, Hagen Fritz
    Jonker, Derek J.
    Chen, Eric Xueyu
    Renouf, Daniel John
    O'Callaghan, Christopher J.
    Loree, Jonathan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 169 - 169
  • [49] The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial
    McQuilten, Zoe
    Wong, Nicholas C.
    Leichter, Anna
    Thao, Le T. P.
    Phung, James
    Murphy, Andrew J.
    Riaz, Moeen
    Sebra, Robert
    Bick, Alexander G.
    McNeil, John J.
    Wolfe, Rory
    Woods, Robyn L.
    Lacaze, Paul
    Wood, Erica M.
    Curtis, David J.
    BLOOD, 2022, 140 : 2238 - 2239
  • [50] Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders
    Matos, Daniel Mazza
    Vitoriano de Oliveira, Ana Cesarina
    Amaral Tome, Maria de Nazare
    Scrideli, Carlos Alberto
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3557 - 3560
12345